Biomedical Engineering Reference
In-Depth Information
[75] Bothun gD, lelis a, Chen Y, scully K, anderson le, stoner Ma. Multicomponent
folate-targeted magnetoliposomes: design, characterization, and cellular uptake.
nanomedicine 2011;
7
:797-805.
[76] silindir M, erdogan s, ozer aY, Maia s. liposomes and their applications in molecular
imaging. J Drug Target 2012;
20
:401-415.
[77] strijkers gJ, Kluza e, van Tilborg ga, van der schaft DW, griffioen aW, Mulder WJ,
nicolay K. paramagnetic and fluorescent liposomes for target-specific imaging and
therapy of tumor angiogenesis. angiogenesis 2010;
13
:161-173.
[78] Boerman oC, laverman p, oyen WJ, Corstens Fh, storm g. radiolabeled liposomes for
scintigraphic imaging. prog lipid res 2000;
39
:461-475.
[79] Torchilin vp. liposomes as delivery agents for medical imaging. Mol Med Today
1996;
2
:242-249.
[80] gore JC, sostman hD, Caride vJ. liposomes for paramagnetic contrast enhancement in
n.m.r. imaging. J Microencapsul 1986;
3
:251-264.
[81] Caride vJ. liposomes as carriers of imaging agents. Crit rev Ther Drug Carrier syst
1985;
1
:121-153.
[82] Zhang D, Feng XY, henning TD, Wen l, lu WY, pan h, Wu X, Zou lg. Mr imaging
of tumor angiogenesis using sterically stabilized gd-DTpa liposomes targeted to CD105.
eur J radiol 2009;
70
:180-189.
[83] petersen al, hansen ae, gabizon a, andresen Tl. liposome imaging agents in person-
alized medicine. adv Drug Deliv rev 2012;
64
:1417-1435.
[84] li s, goins B, Zhang l, Bao a. novel multifunctional theranostic liposome drug delivery
system: construction, characterization, and multimodality Mr, near-infrared fluorescent,
and nuclear imaging. Bioconjug Chem 2012;
23
:1322-1332.
[85] Fattahi h, laurent s, liu F, arsalani n, elst lv, Muller rn. Magnetoliposomes as
multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
nanomedicine 2011;
6
:529-544.
[86] pradhan p, giri J, rieken F, Koch C, Mykhaylyk o, Doblinger M, Banerjee r, Bahadur D,
plank C. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
J Control release 2010;
142
:108-121.
[87] Chen Y, Bose a, Bothun gD. Controlled release from bilayer-decorated magnetolipo-
somes via electromagnetic heating. aCs nano 2010;
4
:3215-3221.
[88] samad a, sultana Y, aqil M. liposomal drug delivery systems: an update review. Curr
Drug Deliv 2007;
4
:297-305.
[89] Kenny gD, Kamaly n, Kalber Tl, Brody lp, sahuri M, shamsaei e, Miller aD, Bell JD.
novel multifunctional nanoparticle mediates sirna tumour delivery, visualisation and
therapeutic tumour reduction
in vivo
. J Control release 2011;
149
:111-116.
[90] immordino Ml, Dosio F, Cattel l. stealth liposomes: review of the basic science, rationale,
and clinical applications, existing and potential. int J nanomedicine 2006;
1
:297-315.
[91] Maeda h, sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular
drugs, including the epr effect in solid tumor and clinical overview of the prototype
polymeric drug sManCs. J Control release 2001;
74
:47-61.
[92] Muthu Ms, Kulkarni sa, raju a, Feng ss. Theranostic liposomes of Tpgs coating for
targeted co-delivery of docetaxel and quantum dots. Biomaterials 2012;
33
:3494-3501.
[93] honda M, asai T, oku n, araki Y, Tanaka M, ebihara n. liposomes and nanotechnology
in drug development: focus on ocular targets. int J nanomedicine 2013;
8
:495-503.
Search WWH ::
Custom Search